Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014;15(5):2217-20.
doi: 10.7314/apjcp.2014.15.5.2217.

Survival rate of early stage endometrioid adenocarcinoma of endometrium treated at Srinagarind Hospital

Affiliations
Free article

Survival rate of early stage endometrioid adenocarcinoma of endometrium treated at Srinagarind Hospital

Srichai Krusun et al. Asian Pac J Cancer Prev. 2014.
Free article

Abstract

Purpose: To evaluate the survival outcome of early stage endometrioid adenocarcinoma of the endometrium with risk factors for locoregional recurrence treated with combined pelvic external beam radiotherapy (EBRT) and vaginal brachytherapy (VBT) after comprehensive surgery.

Materials and methods: Post-operative radiotherapy by pelvic EBRT and VBT for early stage endometrioid endometrial carcinoma resulted in excellent pelvic control with acceptable complications. This study showed no significant relationships between age, stage, histologic grade and LVSI and overall survival rate.

Results: The 5-year overall survival rate (OS) of early stage endometrioid type of endometrial carcinoma was 85.7%. Acute toxicity occurred in 38.1% of the patients, all of whom were grade 1 or 2. Total late toxicity developed in 42.9% of study group, in which 36.99% of them were grade 1-2 and 4.76% were grade 3-4.

Conclusions: Post-operative radiotherapy by pelvic EBRT and VBT is acceptable for early stage endometrioid endometrial carcinoma, independent of age, stage, histologic grade and LVSI.

PubMed Disclaimer

Similar articles

Cited by

  • Sentinel Lymph Nodes in Endometrial Cancer Update 2018.
    Abdelazim IA, Abu-Faza M, Zhurabekova G, Shikanova S, Karimova B, Sarsembayev M, Starchenko T, Mukhambetalyeva G. Abdelazim IA, et al. Gynecol Minim Invasive Ther. 2019 Aug 29;8(3):94-100. doi: 10.4103/GMIT.GMIT_130_18. eCollection 2019 Jul-Sep. Gynecol Minim Invasive Ther. 2019. PMID: 31544018 Free PMC article. Review.

MeSH terms

LinkOut - more resources